SHZ:000078

Shenzhen Neptunus Bioengineering Co., Ltd. · SHZ · Healthcare · CNY · FY for 2025

Figures on this page computed 2026-11-08 00:02 UTC

Last close

n/aCNY

Market data

We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-07
Reported in
CNY
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-07
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
-2.1%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
-0.1%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
9.41Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-07
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
15.5%Dividend yield
Source
computed
Taken on
2026-11-07
Reported in
CNY
- computed

Safety is the furthest below its sector's middle: 0.19 against 0.58 on the market's range.

Five bars, one line

lens 7 of 9

0.81x

1.88x

0.10x

1.09x

n/a

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Computed2025

Market datan/a

Each against its own average

4 of 5 read

Except where said otherwise: Computed from the filing for 2025

Sales0.81x
Its own average over 10 years, 33.07B.
Profit1.88x
Its own average over 10 years, -299.3M.
Free cash flow0.10x
Its own average over 10 years, -223.4M.
Debt1.09x
Its own average over 10 years, 10.59B.
Pricen/a
Its own average over 0 years. Market data

Free cash flow is furthest from its own average, at 0.10 times.

The filed years, as a table

Each line is 100 at 2016-12-31, the first year we hold.

Filed year	Sales	Profit	Shares in issue
2016-12-31	100.0	100.0	100.0
2017-12-31	183.3	152.1	117.6
2018-12-31	282.1	99.1	119.2
2019-12-31	305.0	49.3	118.6
2020-12-31	294.2	-69.0	117.6
2021-12-31	301.7	22.3	117.8
2022-12-31	278.1	-245.5	117.9
2023-12-31	267.7	-403.9	118.0
2024-12-31	222.8	-285.2	118.0
2025-12-31	196.0	-134.6	118.0

How sales was got

Source: computed
Statement: income
Fiscal year: 2025
Reported in: CNY

How profit was got

Source: computed
Statement: income
Fiscal year: 2025
Reported in: CNY

How shares in issue was got

Source: computed
Statement: income
Fiscal year: 2025
Reported in: CNY

Figures behind the shape

Growth

-7.8%

faster is higher, placed against 4,950 companies as of 2026-11-07

Five-year revenue growth rate-7.8%
Source
computed
Taken on
2026-11-07
Reported in
CNY
- computed
Five-year EPS growth raten/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
CNY
- computed
One-year change in net income52.8%
Source
computed
Taken on
2026-11-07
Reported in
CNY
- computed

Returns on capital

-45.9%

higher is higher, placed against 5,089 companies as of 2026-11-07

Return on invested capitaln/a
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-07
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on equity-45.9%
Net Income / Shareholders' Equity x 100
Source
computed
Taken on
2026-11-07
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on assets-2.1%
Net Income / Total Assets x 100
Source
computed
Taken on
2026-11-07
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025

Margins

9.2%

wider is higher, placed against 3,412 companies as of 2026-11-07

Gross margin9.2%
Gross Profit / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
Operating margin-1.9%
Operating Income / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
Net margin-2.1%
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
Free cash flow margin-0.1%
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025

Price

2.7x

cheaper is higher, placed against 4,362 companies as of 2026-11-07

Price to earningsn/a
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-07
Reported in
CNY
- computed
- Computed from the filing for 2025
Price to book2.7x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
Source
computed
Taken on
2026-11-07
Reported in
CNY
- computed
- Computed from the filing for 2025
- computed
- Computed from the filing for 2025
EV to EBITDA34.8x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
Source
computed
Taken on
2026-11-07
Reported in
CNY
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Price to sales ratio0.1x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
Source
computed
Taken on
2026-11-07
Reported in
CNY
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025

Safety

9.41

safer is higher, placed against 3,227 companies as of 2026-11-07

Debt to equity9.41
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-07
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
Current ratio1.00
Current Assets / Current Liabilities
Source
computed
Taken on
2026-11-07
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
Interest coveragen/a
We do not hold this figure for this company, so there is nothing to place.
Operating Income / Interest Expense
Source
computed
Taken on
2026-11-07
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
Altman Z-Score0.85
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
Source
computed
Taken on
2026-11-07
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025

What it pays out

15.5%

more, and better covered, is higher, placed against 1,091 companies as of 2026-11-07

Dividend yield15.5%
Source
computed
Taken on
2026-11-07
Reported in
CNY
- computed
Payout ration/a
We do not hold this figure for this company, so there is nothing to place.
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
Source
computed
Taken on
2026-11-07
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Dividend cover ratio-0.04x
Source
computed
Taken on
2026-11-07
Reported in
CNY
- computed

Share a finding

A link to the finding, not to you: it carries nothing about your account.